International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10572897
Original Article
Comprehensive Glance at NCDs: Insights from a North-Eastern State on Diabetes, Hypertension and Cardiovascular Risk
 ,
 ,
Published
Jan. 24, 2024
Abstract

Background: With the rampant rise in globalization and urbanization, there is an alarming escalation in the burden of common Non-communicable diseases which are the prime causes of mortality and morbidity especially in a country like India, a country in rapid demographic transition.

Objectives: This study was conducted to estimate the burden of Hypertension and Diabetes along with 10 year fatal and nonfatal cardiovascular risk estimation.

Methods: A cross-sectional population-based study was conducted among adults aged 18 and above in Manipur. The study outcome was to estimate the prevalence of hypertension and diabetes using a validated questionnaire adapted from WHO PEN along with 10 year fatal and non-fatal cardiovascular risk using the WHO/ISH chart. Statistical analyses like mean, chi-square, and logistic regression tests were conducted. P value <0.05 was considered statistically significant.

Results: Of the 560 participants, 27.5% were hypertensive and 10.7% were diabetic. One in three of them had one of the NCDs and 5.7% had NCD multimorbidity. Higher age group [odds ratio (AOR): 5.2], inadequate physical activity [AOR: 2] and overweight [AOR:2] were significantly associated with the burden of hypertension whereas diabetes was significantly associated with higher age group [AOR: 9.5] and abdominal obesity. [AOR: 3]. A quarter of them had 10-19% risk of CVD and 10.7% of the individuals had 20-30% risk of developing CVD in the next 10 years.

Conclusion: A quarter of respondents were hypertensive which mirrors the rule of halves for hypertension, one in 10 of respondents were diabetic and a quarter of them had a CVD risk of 10-19%. Despite the high burden of these diseases, a majority of them were under diagnosed mandating the need for cost-effective, high-quality interventions in low-resource settings.

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
2824 Views
60 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved